Healthcare Trust of America, Inc. (HTA) Reaches $29.02 After 5.00% Down Move; Norcros plc (LON:NXR) Had 4 Bulls

January 4, 2018 - By Richard Conner

Among 4 analysts covering Norcros PLC (LON:NXR), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Norcros PLC had 13 analyst reports since November 12, 2015 according to SRatingsIntel. Numis Securities maintained the shares of NXR in report on Tuesday, June 14 with “Buy” rating. The company was maintained on Monday, November 27 by Canaccord Genuity. Cantor Fitzgerald maintained Norcros plc (LON:NXR) rating on Friday, April 1. Cantor Fitzgerald has “Buy” rating and GBX 270 target. FinnCap maintained it with “Buy” rating and GBX 300 target in Friday, January 22 report. The rating was maintained by Numis Securities on Tuesday, October 11 with “Buy”. On Wednesday, April 12 the stock rating was maintained by Numis Securities with “Buy”. The firm has “Buy” rating given on Thursday, July 6 by Canaccord Genuity. Numis Securities maintained it with “Buy” rating and GBX 300 target in Thursday, November 12 report. On Tuesday, December 12 the stock rating was maintained by Numis Securities with “Buy”. On Thursday, April 14 the stock rating was maintained by Numis Securities with “Buy”. See Norcros plc (LON:NXR) latest ratings:

12/12/2017 Broker: Numis Securities Rating: Buy Old Target: GBX 300.00 New Target: GBX 300.00 Maintain
27/11/2017 Broker: Canaccord Genuity Rating: Buy Old Target: GBX 315.00 New Target: GBX 335.00 Reiteration
06/07/2017 Broker: Canaccord Genuity Rating: Buy Old Target: GBX 217.00 New Target: GBX 315.00 Reiteration

The stock of Healthcare Trust of America, Inc. (NYSE:HTA) is a huge mover today! The stock decreased 2.70% or $0.81 during the last trading session, reaching $29.02. About 783,310 shares traded. Healthcare Trust of America, Inc. (NYSE:HTA) has risen 7.80% since January 4, 2017 and is uptrending. It has underperformed by 8.90% the S&P500.The move comes after 9 months negative chart setup for the $6.07 billion company. It was reported on Jan, 4 by Barchart.com. We have $27.57 PT which if reached, will make NYSE:HTA worth $303.30M less.

Healthcare Trust of America, Inc. is a publicly owned equity real estate investment trust. The company has market cap of $6.07 billion. The firm invests in the real estate markets of the United States. It has a 127.86 P/E ratio. It is engaged in acquiring, owning and operating high-quality medical office buildings located primarily on-campus or affiliated with the nationÂ’s leading healthcare systems.

Among 12 analysts covering Healthcare Trust of America (NYSE:HTA), 10 have Buy rating, 0 Sell and 2 Hold. Therefore 83% are positive. Healthcare Trust of America had 32 analyst reports since August 26, 2015 according to SRatingsIntel. BMO Capital Markets maintained Healthcare Trust of America, Inc. (NYSE:HTA) rating on Tuesday, July 18. BMO Capital Markets has “Buy” rating and $3500 target. The firm has “Buy” rating given on Friday, July 7 by Jefferies. Jefferies maintained Healthcare Trust of America, Inc. (NYSE:HTA) rating on Monday, August 28. Jefferies has “Buy” rating and $34.0 target. The rating was maintained by Stifel Nicolaus with “Buy” on Tuesday, July 4. As per Wednesday, July 12, the company rating was maintained by Stifel Nicolaus. The stock of Healthcare Trust of America, Inc. (NYSE:HTA) earned “Buy” rating by Jefferies on Monday, June 5. The firm has “Buy” rating given on Tuesday, October 24 by BMO Capital Markets. The firm earned “Outperform” rating on Tuesday, June 20 by BMO Capital Markets. The firm has “Buy” rating given on Wednesday, January 4 by Mizuho. On Monday, October 2 the stock rating was maintained by BMO Capital Markets with “Buy”.

Analysts await Healthcare Trust of America, Inc. (NYSE:HTA) to report earnings on February, 21. They expect $0.42 EPS, 0.00% or $0.00 from last year’s $0.42 per share. HTA’s profit will be $87.79M for 17.27 P/E if the $0.42 EPS becomes a reality. After $0.42 actual EPS reported by Healthcare Trust of America, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Norcros plc, together with its subsidiaries, develops, makes, markets, and exports home consumer products in the United Kingdom, South Africa, and internationally. The company has market cap of 143.91 million GBP. The firm makes and distributes electric, and mixer showers and accessories under the Triton brand name; taps, mixer showers, bathroom accessories, and valves under the Vado brand name; and bathroom furnishings and accessories under the Croydex brand name. It has a 14.52 P/E ratio. It also offers kitchen taps, sinks, bathroom brassware, and showering solutions under the Abode brand name; ceramic wall and floor tiles under the Johnson Tiles brand name; and adhesives, grouts, and surface preparation products under the Norcros Adhesives brand name for fixing ceramic and porcelain tiles, mosaics, natural stones, and marbles.